MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: other"

  • 2026 International Congress

    Outcomes of a new electromyography-guided botulinum toxin injection clinic for medication-refractory upper limb tremor

    R. Hoe, S. Neo (Singapore, Singapore)

    Objective: To describe the outcomes of a new electromyography (EMG)-guided botulinum toxin (BT) clinic for treatment of tremor in our center. Background: Tremor is often…
  • 2026 International Congress

    Digital Facial Movement Analysis in Hemifacial Spasm: Potential and Limitations as a Clinical Biomarker

    Z. Kosutzka, S. Sepelak, V. Hudzikova (Bratislava, Slovakia)

    Objective: To evaluate the potential use of digital biomarkers in the treatment assessment of hemifacial spasm (HFS) using botulinum toxin, also assessed with conventional methods…
  • 2026 International Congress

    Beyond Symptom Relief: Physician Empathy Outperforms Clinical Severity in Predicting Quality of Life for Patients Undergoing Botulinum Toxin Therapy

    T. Kölsche, R. Jansen, M. Ringelstein, S. Meuth, J. Lee, P. Albrecht (Düsseldorf, Germany)

    Objective: To evaluate the impact of patient-perceived physician empathy on health-related quality of life (HRQoL), treatment satisfaction, and clinical outcomes in patients receiving Botulinum Neurotoxin…
  • 2026 International Congress

    Five-Year Real-World Outcomes Of Botulinum Toxin Injections For Sialorrhoea In Parkinson’s

    R. Biju, B. Mohamed, J. Adenwalla, C. Thomas, S. Aviet (Cardiff, United Kingdom)

    Objective: 1. Assess real‑world outcomes of Botulinum Toxin A (BoNT-A) therapy for sialorrhoea in Parkinson’s disease by evaluating changes in Drooling Severity and Frequency Scale…
  • 2026 International Congress

    Non-Motor Symptoms in Hemifacial Spasm: A Cross-Sectional Study from a Brazilian Public Tertiary Center

    M. Soares, M. Silva, JA. de Albuquerque, C. Franco, PA. Rocha Filho (Recife, Brazil)

    Objective: To determine clinical characteristics of non-motor symptoms in patients with primary hemifacial spasm (HFS) at a tertiary public center in Brazil. Background: HFS is…
  • 2025 International Congress

    Botulinum toxin therapy in patients with Hemifacial spasm: beyond the treatment of motor symptoms.

    MB. Charra Castellani, MV. Kurtz, E. Knorre, D. Ballesteros (Buenos Aires, Argentina)

    Objective: Evaluate the quality of life and the presence of anxiety and depression in HFS patients and their behavior after botulinum toxin administration. Background: Hemifacial…
  • 2025 International Congress

    Hypersensitivity Reaction to Abobotulinumtoxin: A Case Report

    T. Le, M. Christie (Houston, USA)

    Objective: To report a case of hypersensitivity reaction to abobotulinumtoxinA injections for spasticity in a patient who did not have hypersensitivity to onabotulinumtoxinA and raise…
  • 2025 International Congress

    Simple and Effective OnabotulinumtoxinA Injection Technique for Hemifacial Spasm

    K. Fungpunyaroj, P. Chairangsaris (Bangkok, Thailand)

    Objective: In order to determine fixed-site and fixed-dose BoNT injections for HFS were easy to administer, safe, efficacious, well-tolerated, and practical this study aims to…
  • 2025 International Congress

    Physician Assessment of Non-Medical Toxin Switching on Patient Care

    P. Charles, L. Venditti, M. Nelson, R. Singh, K. Pazira, H. Kling, L. Kopaeva, S. Sharp, K. Harper (Nashville, USA)

    Objective: To gain an understanding from physicians on the impact of non-medical toxin switching (NMTS) in the treatment of movement disorders and other chronic conditions…
  • 2025 International Congress

    IncobotulinumtoxinA to Treat Sialorrhea in Parkinson’s Disease: a Real-life Study: 6-year Interim Results

    B. Bergmans, N. Winter, V. Schotte, N. Sys, E. van Massenhove, G. Pollet, H. Couckuyt, L. Delameilleure, M. van Zandijcke (Bruges, Belgium)

    Objective: We evaluate the long-term efficacy and safety of incobotulinumtoxinA injections in advanced Parkinson’s disease (PD) patients suffering from sialorrhea. Background: Sialorrhea is frequently a…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 15
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley